SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jubilant Pharmova - Quaterly Results

07 Feb 2026 Evaluate
The Revenue for the quarter ended  December 2025 of Rs. 673.00 millions grew by 19.96 % from Rs. 561.00 millions.Net Profit witnessed a 153.85% growth almost the double from Rs. 26.00 millions to Rs. 66.00  millions  of same quarter last year.OP of the company witnessed a marginal growth to 126.00 millions from 101.00 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 673.00 561.00 19.96 1932.00 1707.00 13.18 7457.00 7847.00 -4.97
Other Income 4.00 1.00 300.00 19.00 199.00 -90.45 996.00 1034.00 -3.68
PBIDT 126.00 101.00 24.75 362.00 497.00 -27.16 1317.00 1199.00 9.84
Interest 9.00 33.00 -72.73 64.00 98.00 -34.69 298.00 299.00 -0.33
PBDT 117.00 68.00 72.06 298.00 399.00 -25.31 907.00 900.00 0.78
Depreciation 16.00 15.00 6.67 47.00 51.00 -7.84 531.00 483.00 9.94
PBT 101.00 53.00 90.57 251.00 348.00 -27.87 376.00 417.00 -9.83
TAX 35.00 27.00 29.63 624.00 135.00 362.22 184.00 101.00 82.18
Deferred Tax 17.00 -36.00 -147.22 580.00 -20.00 -3000.00 -14.00 33.00 -142.42
PAT 66.00 26.00 153.85 -373.00 213.00 -275.12 192.00 316.00 -39.24
Equity 159.00 159.00 0.00 159.00 159.00 0.00 159.00 159.00 0.00
PBIDTM(%) 18.72 18.00 3.99 18.74 29.12 -35.65 17.66 15.28 15.59

Jubilant Pharmova Share Price

891.75 12.80 (1.46%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×